R&D Beyond animal testing: How human data trials are reshaping d... Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.
News CMS aims for broader GLP-1 access via federal programmes CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.